期刊
PEDIATRIC ALLERGY AND IMMUNOLOGY
卷 -, 期 -, 页码 -出版社
WILEY
DOI: 10.1111/pai.13250
关键词
early life; eczema; immune cell profiles; randomised controlled trial; vitamin D supplementation
资金
- WA Child Research Fund, Australia
- Asthma Foundation of Western Australia, Australia
- Princess Margaret Hospital Foundation, Australia
Background Low vitamin D levels have been associated with allergic diseases. Vitamin D has potent immunomodulatory properties, but the mechanisms remain unclear. We have investigated the effect of oral vitamin D supplementation on circulating immune cell phenotypes in infants. Method A double-blinded randomised controlled trial was conducted to investigate the effect of oral vitamin D supplementation (400 IU/d) on eczema and immune development. A subset of 78 infants was included in this analysis. Phenotypic analysis of immune cell subsets was performed using flow cytometry. Results Vitamin D supplementation resulted in median 25(OH)D levels of 80.5 vs 59.5 nmol/L in the placebo group at 3 months of age (P = .002) and 87.5 vs 77 nmol/L at 6 months of age (P = .08). We observed significant changes in immune cell composition from birth (cord blood) to 6 months of age. Vitamin D supplementation did not impact these changes, nor did immune cell composition correlate with plasma 25(OH)D levels. Through exploratory analysis, we identified possible associations with eczema development and increased abundance of naive CD4(-) T cells at birth, as well as associations with basophils, iNKT and central memory CD4(+) T cells, and altered expression patterns of IgE receptor (Fc epsilon R1) on monocytes and dendritic cells with eczema at 6 months. Conclusions Vitamin D supplementation in infants who were vitamin D sufficient at birth did not affect developmental changes in immune cells during the first 6 months of life. However, immune cell profiles at birth and at 6 months of age were associated with early life eczema.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据